Botulinum Neurotoxin Type A for the Treatment of Benign Prostatic Hyperplasia: Randomized Study Comparing Two Doses

Purpose. To assess the efficacy and safety of intraprostatic injection of two botulinum neurotoxin type A (BoNT-A) doses for the treatment of benign prostatic hyperplasia (BPH). Materials and Methods. Men with symptomatic BPH who failed medical treatment were randomized to receive 100 U or 200 U of...

Descripción completa

Detalles Bibliográficos
Autores principales: Arnouk, René, Suzuki Bellucci, Carlos Henrique, Stull, Roberto Benatuil, de Bessa Junior, José, Malave, Cesar Augusto, Gomes, Cristiano Mendes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Scientific World Journal 2012
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446647/
https://www.ncbi.nlm.nih.gov/pubmed/22997495
http://dx.doi.org/10.1100/2012/463574

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446647/
https://www.ncbi.nlm.nih.gov/pubmed/22997495
http://dx.doi.org/10.1100/2012/463574

Ejemplares similares